<DOC>
	<DOCNO>NCT02613169</DOCNO>
	<brief_summary>Randomized control trial ( RCT ) isoniazid ( INH ) vs. INH prevent Mycobacterium tuberculosis infection HIV-exposed uninfected ( HEU ) infant .</brief_summary>
	<brief_title>Infant TB Infection Prevention Study</brief_title>
	<detailed_description>The purpose trial determine whether isoniazid ( INH ) reduce risk Mycobacterium tuberculosis ( MTB ) infection HIV-exposed uninfected ( HEU ) child , well determine epidemiologic immunologic correlate MTB infection HEU .</detailed_description>
	<mesh_term>Infection</mesh_term>
	<mesh_term>Tuberculosis</mesh_term>
	<mesh_term>Isoniazid</mesh_term>
	<criteria>HIV expose infant Aged 6 week within ( + 4 week ) Born HIVinfected mother Not premature 2.5 kg Infants know exposure active TB household Premature &lt; 2.5 kg</criteria>
	<gender>All</gender>
	<minimum_age>6 Weeks</minimum_age>
	<maximum_age>10 Weeks</maximum_age>
	<verification_date>September 2016</verification_date>
	<keyword>M. tuberculosis infection</keyword>
	<keyword>isoniazid</keyword>
	<keyword>HIV-exposed infant</keyword>
</DOC>